If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPERE.L Regulatory News (PERE)

  • There is currently no data for PERE

Director Share Purchase

19 Dec 2016 10:06

RNS Number : 2313S
China Africa Resources PLC
19 December 2016
 

China Africa Resources PLC

19 December 2016

China Africa Resources plc

("China Africa" or the "Company")

 

Director Share Purchase

 

 

China Africa Resources plc (LON:CAF) the London Stock Exchange AIM listed natural resource exploration and development company is pleased to announce that Paul Johnson, Chief Executive Officer, today purchased 107,858 shares in the Company at a price of 2.045p.

 

Following this purchase Paul Johnson, and spouse Michelle Johnson, hold 6,500,000 shares representing 8.57% of issued share capital.

 

 

For further information on the Company, visit: http://www.chinaafricares.com/.

 

China Africa Resources PLC

Paul Johnson, Chief Executive Officer

 

T: +44 (0) 1707 800774

SPARK Advisory Partners - Nominated Adviser

Sean Wyndham-Quin

Neil Baldwin

 

T: +44 (0) 2033 683 555

 

www.sparkadvisorypartners.com

SI Capital Limited - Joint Broker

Nick Emerson

Andy Thacker

 

T: +44 (0) 1483 413 500

Beaufort Securities Limited - Joint Broker

Elliot Hance

T: +44 (0) 207 382 8300

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHFFIFSUFMSESE
Date   Source Headline
15th May 20174:41 pmRNSPosting of Notice of AGM
12th May 20177:00 amRNSResults for the Year Ended 31 December 2016
3rd May 20175:06 pmRNSUpdate on AIM Rule 15 status
18th Apr 20177:00 amRNSSenior Management Appointment
11th Apr 20178:28 amRNSTR-1: Notification of major interest in shares
10th Apr 20177:00 amRNSAppointment of Shard Capital Partners as Broker
10th Apr 20177:00 amRNSSenior Management Appointment
7th Apr 201711:20 amRNSChange of Name, Registered Address and Update
28th Mar 20175:59 pmRNSTR-1: Notification of Major Interest in Shares
23rd Mar 20179:34 amRNSChange of Name
16th Mar 20173:51 pmRNSHolding in Company
9th Mar 20177:00 amRNSSenior Management Appointment
2nd Mar 20178:26 amRNSAppointment of Frank McAllister to Advisory Board
2nd Mar 20177:00 amRNSChange of Name and Notice of GM
28th Feb 20178:40 amRNSAppointment of Guy Le Bel to Advisory Board
20th Feb 20178:11 amRNSNotifiable Holding
17th Feb 20171:36 pmRNSBoard Changes
8th Feb 201710:00 amRNSInvestment Agreement - USA Lithium
1st Feb 20177:00 amRNSInvestment Agreement Botswana
26th Jan 20178:04 amRNSChange of Adviser
11th Jan 20178:17 amRNSCompletion of In-Specie Distribution Process
30th Dec 20168:53 amRNSStrategic and Operational Update
29th Dec 201610:00 amRNSChange of Registered Office
19th Dec 201610:06 amRNSDirector Share Purchase
14th Dec 20161:11 pmRNSResult of GM
25th Nov 20169:14 amRNSNotice of GM
21st Nov 201612:38 pmRNSFurther re Capital Reorganisation
21st Nov 20169:22 amRNSCapital Reorganisation
16th Nov 201610:18 amRNSShare Price Movement
11th Aug 201612:34 pmRNSShare Price Movement
27th Jul 201611:12 amRNSHalf-year Report
7th Jul 20163:16 pmRNSResult of AGM
14th Jun 20162:57 pmRNSNotice of AGM
17th May 201611:03 amRNSAnnual Financial Report
9th May 20167:00 amRNSFinal Results
27th Apr 201611:20 amRNSChange of Address
16th Nov 201511:15 amRNSLoan from HK ECE and Directorate Change
3rd Sep 20157:00 amRNSInterim Results
9th Jun 20151:00 pmRNSResult of AGM
6th May 20159:34 amRNSNotice of AGM and Posting of Annual Report
13th Apr 20157:00 amRNSChange of Address
4th Mar 20157:00 amRNSFinal Results
10th Sep 20147:00 amRNSDirectorate Changes
10th Sep 20147:00 amRNSInterim Results
17th Jul 20146:00 pmRNSDirectorate Change
10th Jun 201412:53 pmRNSResult of AGM
3rd Jun 20147:00 amRNSNotice of AGM and Posting of Annual Report
27th May 20147:00 amRNSBerg Aukas Pre Feasibility Study Results
14th Mar 20147:00 amRNSFinal Results
29th Jan 20147:00 amRNSUpdate on Feasibility Study

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.